The European Patent Office has sustained an earlier decision that invalidates stem cell patents owned by Geron and the Wisconsin Alumni Research Foundation. Geron did not give further details on the ruling, which comes a week after the biotech firm obtained FDA approval to conduct human trials involving stem cells.

Full Story:

Related Summaries